- The Peel
- Posts
- Stocks Bounce Before Nvidia
Stocks Bounce Before Nvidia
Falling oil and yields lifted Tuesday’s rebound, but Nvidia and PCE now take over.

Market Snapshot

Get a Top Job Offer, Guaranteed (or tuition is free) | Apply Here
📉 Banana Bits
Tech rebounds as falling oil and Treasury yields lift Wall Street ahead of Nvidia.
New U.S. home sales slide in July as high mortgage rates keep buyers sidelined.
U.S. consumer confidence falls to a seven-month low as economic expectations weaken.
Gold hits a three-month high as investors await U.S. inflation data.
Market News
Stocks Rebound as Oil Falls and Nvidia Takes Center Stage
Wall Street bounced back Tuesday, with the S&P 500 rising 0.3%, the Dow gaining 160 points, and the Nasdaq climbing 0.7%. The biggest relief came from oil: Brent crude fell 3.9% Tuesday to settle at $88.58 a barrel, its second straight decline. The slide continued Wednesday morning, with Brent dropping another 3% to around $85.84, which helped calm concerns that expensive energy could keep inflation high. Treasury yields also moved lower Tuesday, with the 10-year yield falling from about 4.70% to 4.63%, giving stocks another boost. Tech led the rebound on Tuesday after getting hit Monday, with semiconductor stocks recovering ahead of Nvidia’s highly anticipated earnings today after the close. Nvidia itself gained about 2.2%, as investors positioned for a report that could help determine whether the recent AI selloff was just a pullback or something more serious.

Source: YahooFinance
It wasn’t all good news. U.S. consumer confidence fell more than expected, adding to concerns that higher prices and a weaker job market may be starting to weigh on spending. Dick’s Sporting Goods also plunged more than 30% after disappointing earnings and a weaker profit outlook, showing how quickly investors are punishing companies that miss expectations. Still, falling oil prices and lower bond yields were enough to outweigh those concerns Tuesday. Now the focus shifts to July PCE at 8:30 a.m. ET today and Nvidia’s results after the close, two events that could determine whether this rebound has room to continue.
Peel Take: Tuesday gave investors exactly what they wanted after Monday’s weakness: cheaper oil, lower yields, and a tech rebound. But today is the real test. Nvidia has become the market’s unofficial report card for the AI boom, and expectations are already extremely high. A strong report could quickly bring buyers back into chips, while anything disappointing could restart the selloff. Falling oil is helping for now, but with consumer confidence weakening and inflation data coming up, there are still plenty of reasons for Wall Street to stay cautious.
What's Ripe
Moderna (MRNA) 14.36%
Moderna surged 14.36% as Wall Street continued to reprice the stock following encouraging long-term results from its personalized cancer vaccine trial with Merck. Barclays sharply raised its price target to $125 from $48, pointing to the broader potential of Moderna’s oncology pipeline.
The news is especially important because investors have been looking for Moderna to prove it can expand beyond its COVID vaccine business. Today’s move suggests the market sees cancer treatments as a potentially major new source of growth.
Peel Take: Moderna desperately needed a story that wasn't spelled C-O-V-I-D, and cancer vaccines could be it. A 14% jump doesn't mean the treatment is guaranteed to become a blockbuster, but positive long-term data gives investors something much bigger to focus on. If Moderna can turn its mRNA technology into a successful cancer business, today's rally could be about more than just one good headline.
Advanced Micro Devices (AMD) 4.91%
AMD rallied 4.91% after Raymond James upgraded the stock to Strong Buy from Outperform and raised its price target to $641 from $565, citing AMD’s growing opportunity in server CPUs supporting AI workloads.
The move also came as semiconductor stocks rebounded from Monday’s selloff, with investors returning to AI names ahead of Nvidia’s earnings today after the close.
Peel Take: Monday chips were toxic; Tuesday AMD got an upgrade and suddenly everyone remembered AI still needs processors. The bigger story is that investors haven’t abandoned the AI trade, they’re just getting pickier about what they’re willing to pay for it. Nvidia’s results after today’s close could decide whether Tuesday’s chip rebound has legs.
What's Rotten
Dick’s Sporting Goods (DKS) 30.68%
Dick's got crushed after missing quarterly expectations and cutting its full-year outlook, with weakness in athletic footwear weighing on results.
Its recently acquired Foot Locker business was a major source of the disappointment, as weak demand for legacy footwear brands and underperforming product launches pressured sales and forced Dick’s to lower its expectations for the business.
Peel Take: A 30% haircut is Wall Street's way of saying this wasn't just a bad quarter. Dick's spent billions buying Foot Locker, and investors now want proof that the deal can actually improve the business rather than become an expensive headache. When you miss earnings and cut the outlook, there aren't many places for shareholders to hide.
Nike (NKE) 3.12%
Nike fell alongside the weakness in Dick's after the retailer highlighted continued softness in athletic footwear, raising concerns about demand across the broader sneaker market.
The brand also faced renewed controversy, adding another negative headline on a day when investors were already worried about consumer demand.
Peel Take: Dick's sneezed and Nike caught the cold. A weak outlook from one of America's biggest sporting-goods retailers isn't exactly what Nike investors want to hear when the company is already trying to strengthen growth. Nike's drop was nowhere near Dick's disaster, but Tuesday's message was clear: selling sneakers isn't as easy as it used to be.
🧠 Technical Trip
Interview Q&A from Lazard

👉 Want 1-on-1 recruiting help from Lazard bankers & 5,000+ top mentors? Apply to WSO Academy
🦈 Deal Dispatch
M&A, IPOs, And Other Notable Transactions
McKesson agrees to acquire Precision Medicine Group for approximately $2.25 billion.
Valley National agrees to acquire Providence Financial in a $247 million cash-and-stock deal.
Accenture agrees to acquire Dutch SAP specialist McCoy to expand its mid-market capabilities.
Navitas agrees to acquire Claros for up to $232.8 million in cash and stock
Banana Brain Teaser
Previous
An investor buys a bond for $960, receives a $40 coupon one year later, then sells the bond for $980. What was the investor’s total one-year return?
Answer: 6.25%
Today
A portfolio is 60% stocks and 40% bonds. Stocks rise 10% and bonds fall 5%. What is the portfolio return?
The investor’s chief problem, and even his worst enemy, is likely to be himself.
How Would You Rate Today's Peel?
Happy Investing,
Chris, Elie, Mitchell, Fernanda, Nick, & Patrick

